| Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial O Hermine, X Mariette, PL Tharaux, M Resche-Rigon, R Porcher, ... JAMA internal medicine 181 (1), 32-40, 2021 | 918 | 2021 |
| Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial PL Tharaux, G Pialoux, A Pavot, X Mariette, O Hermine, M Resche-Rigon, ... The Lancet Respiratory Medicine 9 (3), 295-304, 2021 | 266 | 2021 |
| A 5-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae: a randomized clinical trial BD Huttner, V De Lastours, M Wassenberg, N Maharshak, A Mauris, ... Clinical microbiology and infection 25 (7), 830-838, 2019 | 163 | 2019 |
| Histoire et principes de la vaccination E Canouï, O Launay Revue des maladies respiratoires 36 (1), 74-81, 2019 | 101 | 2019 |
| HIV infection and COVID-19: risk factors for severe disease N Etienne, M Karmochkine, L Slama, J Pavie, D Batisse, R Usubillaga, ... Aids 34 (12), 1771-1774, 2020 | 89 | 2020 |
| A subset of extreme human immunodeficiency virus (HIV) controllers is characterized by a small HIV blood reservoir and a weak T-cell activation level E Canouï, C Lécuroux, V Avettand-Fenoël, M Gousset, C Rouzioux, ... Open forum infectious diseases 4 (2), ofx064, 2017 | 52 | 2017 |
| Use of ceftolozane/tazobactam as salvage therapy for infections due to extensively drug-resistant Pseudomonas aeruginosa A Dinh, B Wyplosz, S Kernéis, D Lebeaux, F Bouchand, C Duran, ... International journal of antimicrobial agents 49 (6), 782-783, 2017 | 43 | 2017 |
| Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial X Mariette, O Hermine, PL Tharaux, M Resche-Rigon, R Porcher, ... The Lancet Rheumatology 4 (1), e24-e32, 2022 | 40 | 2022 |
| Comparing dynamics and determinants of SARS-CoV-2 transmissions among health care workers of adult and pediatric settings in central Paris A Contejean, J Leporrier, E Canouï, F Alby-Laurent, E Lafont, L Beaudeau, ... medRxiv, 2020.05. 19.20106427, 2020 | 37 | 2020 |
| Antimicrobial stewardship in high-risk febrile neutropenia patients A Contejean, S Abbara, R Chentouh, S Alviset, E Grignano, N Gastli, ... Antimicrobial Resistance & Infection Control 11 (1), 52, 2022 | 26 | 2022 |
| Osteoarticular manifestations of Q fever: a case series and literature review E Meriglier, A Sunder, A Elsendoorn, E Canoui, B Rammaert, M Million, ... Clinical Microbiology and Infection 24 (8), 912-913, 2018 | 24 | 2018 |
| Usefulness of plasma SARS-CoV-2 RNA quantification by droplet-based digital PCR to monitor treatment against COVID-19 in a B-cell lymphoma patient TA Szwebel, D Veyer, N Robillard, D Eshagh, E Canoui, T Bruneau, ... Stem Cell Reviews and Reports 17, 296-299, 2021 | 19 | 2021 |
| Combination of vancomycin plus piperacillin and risk of acute kidney injury: a worldwide pharmacovigilance database analysis A Contejean, M Tisseyre, E Canouï, JM Treluyer, S Kerneis, L Chouchana Journal of Antimicrobial Chemotherapy 76 (5), 1311-1314, 2021 | 16 | 2021 |
| Antimicrobial for 7 or 14 days for febrile urinary tract infection in men: a multicenter noninferiority double-blind, placebo-controlled, randomized clinical trial M Lafaurie, S Chevret, JP Fontaine, P Mongiat-Artus, V De Lastours, ... Clinical Infectious Diseases 76 (12), 2154-2162, 2023 | 15 | 2023 |
| Comparing dynamics and determinants of severe acute respiratory syndrome coronavirus 2 transmissions among healthcare workers of adult and pediatric settings in central Paris A Contejean, J Leporrier, E Canouï, F Alby-Laurent, E Lafont, L Beaudeau, ... Clinical Infectious Diseases 72 (2), 257-264, 2021 | 15 | 2021 |
| Large retrospective study analysing predictive factors of primary treatment failure, recurrence and death in pyogenic liver abscesses G Rossi, Y Nguyen, E Lafont, B Rossi, E Canouï, O Roux, S Dokmak, ... Infection 50 (5), 1205-1215, 2022 | 14 | 2022 |
| The value of molecular techniques to diagnose Ureaplasma urealyticum and Nocardia farcinica pleuropneumonia in a patient with diffuse large B-cell lymphoma E Canouï, K Blanc, J Loubinoux, S Valade, C Hamard, A Lefebvre, ... International Journal of Infectious Diseases 64, 93-95, 2017 | 13 | 2017 |
| IgG4-related disease and hypereosinophilic syndrome: overlapping phenotypes A Moussiegt, R Mueller, M Ebbo, A Grados, J Graveleau, F Ackermann, ... Autoimmunity reviews 20 (9), 102889, 2021 | 12 | 2021 |
| plasma concentrations and safety of lopinavir/ritonavir in COVID-19 patients L Chouchana, S Boujaafar, I Gana, LH Preta, L Regard, P Legendre, ... Therapeutic Drug Monitoring 43 (1), 131-135, 2021 | 12 | 2021 |
| Clinical characteristics and persistence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG antibodies in 4,607 French healthcare workers: comparison with … C Delmas, G Plu-Bureau, E Canouï, L Mouthon, JF Meritet Infection Control & Hospital Epidemiology 42 (11), 1406-1408, 2021 | 11 | 2021 |
